Clinical information and resources are available in multiple languages.
Medtronic Neuromodulation has entered in an agreement with the U.S. Food and Drug Administration (FDA) related to the SynchroMed™ II drug infusion system and the Neuromodulation quality system.
Provided on this website relating to the agreement are:
- Resources for clinicians
- Press release